A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer

Bone Marrow Transplantation

Volumn 25, Issue 1, 2000, Pages 5-11

  Takahashi, M ^a   Yoshizawa, H ^a   Tanaka, H ^a   Tanaka, J ^a   Kagamu, H ^a   Ito, K ^a   Shimbo, T ^a   Chou, D ^a   Wakabayashi, M ^a   Suzuki, E ^a   Sakai, K ^a   Arakawa, M ^a   Gejyo, F ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Dose intensive chemotherapy; Granulocyte colony stimulating factor; Hematopoietic stem cell transplantation; Leukapheresis; Small cell lung cancer

Indexed keywords

CARBOPLATIN; ETOPOSIDE; IFOSFAMIDE; NARCOTIC AGENT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; STEROID;

ADULT; AGED; ARTICLE; ATAXIA; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER RADIOTHERAPY; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COUGHING; CRYOPRESERVATION; FEMALE; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN CELL; LEUKAPHERESIS; LEUKOCYTE COUNT; LEUKOPENIA; LIVER TOXICITY; LUNG SMALL CELL CANCER; MALE; MAXIMUM PERMISSIBLE DOSE; NAUSEA; NEPHROTOXICITY; PERIPHERAL BLOOD STEM CELL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; RESPIRATORY DISTRESS; STEM CELL TRANSPLANTATION; VOMITING;

EID: 17444451710     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702088     Document Type: Article

References (26)

1. Gurney H, Dodwell D, Thatcher N, Tattersall MH. Escalating drug delivery in cancer chemotherapy: a review of concepts and practice - part 1. Ann Oncol 1993; 4: 23-34.
2. Gurney H, Dodwell D, Thatcher N, Tattersall MH. Escalating drug delivery in cancer chemotherapy: a review of concepts and practice - part 2. Ann Oncol 1993; 4: 103-115.
3. Coldman AJ, Goldie JH. Impact of dose-intense chemotherapy on the development of permanent drug resistance. Semin Oncol 1987; 14 (Suppl. 4): 29-33.
4. DeVita VT Jr. The influence of information on drug resistance on protocol design. Ann Oncol 1991; 2: 93-106.
5. Arriagada R, Le Chevalier T, Pignon JP et al. Initial chemotherapeutic doses and survival in patients with limited small-cell lung cancer. New Engl J Med 1993; 329: 1848-1852.
6. Humblet Y, Symann M, Bosly A et al. Late intensification chemotherapy with autologous bone marrow transplantation in selected small-cell carcinoma of the lung: a randomized study. J Clin Oncol 1987; 5: 1864-1873.
7. Shea TC, Mason JR, Storniolo AM et al. Sequential cycles of high-dose carboplatin administered with recombinant human granulocyte-macrophage colony-stimulating factor and repeated infusions of autologous peripheral blood progenitor cells: a novel and effective method for delivering multiple courses of dose-intensive therapy. J Clin Oncol 1992; 10: 464-473.
8. Tepler I, Cannistra SA, Frei E et al. Use of peripheral blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy. J Clin Oncol 1993; 11: 1583-1591.
9. Pettengell R, Woll PJ, Thatcher N et al. Multicyclic, dose-intensive chemotherapy supported by sequential reinfusion of hematopoietic progenitors in whole blood. J Clin Oncol 1995; 13: 148-156.
10. Kohno A, Takeyama K, Narabayashi M et al. Low-dose granulocyte colony-stimulating factor enables the efficient collection of peripheral blood stem cells after disease-oriented, conventional-dose chemotherapy for breast cancer, malignant lymphoma and germ cell tumor. Bone Marrow Transplant 1995; 15: 49-54.
11. 2) after salvage chemotherapy for lymphoma. Bone Marrow Transplant 1997; 20: 855-858.
12. Hryniuk W, Bush H. The importance of dose intensity in chemotherapy of metastatic breast cancer. J Clin Oncol 1984; 2: 1281-1288.
13. Smith IE, Perren TJ, Ashley SA et al. Carboplatin, etoposide, and ifosfamide as intensive chemotherapy for small-cell lung cancer. J Clin Oncol 1990; 8: 899-905.
14. Gatzemeier U, Hossfeld DK, Neuhauss R et al. Combination chemotherapy with carboplatin, etoposide, and vincristine as first-line treatment in small-cell lung cancer. J Clin Oncol 1992; 10: 818-823.
15. Loehrer PJ Sr, Rynard S, Ansari R et al. Etoposide, ifosfamide, and cisplatin in extensive small cell lung cancer. Cancer 1992; 69: 669-673.
16. Seifter EJ, Ihde DC. Therapy of small cell lung cancer: a perspective on two decades of clinical research. Semin Oncol 1988; 15: 278-299.
17. Skarlos DV, Samantas E, Kosmidis P et al. Randomized comparison of etoposide-cisplatin vs etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study. Ann Oncol 1994; 5: 601-607.
18. Thatcher N, Ifosfamide/carboplatin/etoposide (ICE) regimen in small cell lung cancer. Lung Cancer 1993; 9: S51-S67.
19. Blackstein ME. Advances in chemotherapy for small cell lung cancer. Semin Oncol 1994; 21 (Suppl. 1): 38-42.
20. Van der Wall E, Richel DJ, Holtkamp MJ et al. Bone marrow reconstitution after high-dose chemotherapy and autologous peripheral blood progenitor cell transplantation: effect of graft size. Ann Oncol 1994; 5: 795-802.
21. Woll PJ, Hodgetts J, Lomax L et al. Can cytotoxic dose intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancer. J Clin Oncol 1995; 13: 652-659.
22. Thatcher N, Sambrook RJ, Stephens RJ et al. Dose intensification (DI) with G-CSF improves survival in small cell lung cancer (SCLC): results of a randomized trial. Proc Am Soc Clin Oncol 1998; 18: (Abstr. 1754) 17456a.
23. Pignon JP, Arriagada R, Ihde DC et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer (see comments). New Engl J Med 1992; 327: 1618-1624.
24. Murray N, Coy P, Pater JL et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 1993; 11: 336-344.
25. Perry MC, Herndon JE, Eaton WL, Green MR. Thoracic radiation therapy added to chemotherapy for small-cell lung cancer: an update of Cancer and Leukemia Group B Study 8083. J Clin Oncol 1998; 16: 2466-2467.
26. Turrisi AT, Kim K, Blum R et al. Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide. New Engl J Med 1999; 340: 265-271.